Reinilde Heyrman
Chief Tech/Sci/R&D Officer at MEDPACE HOLDINGS, INC.
Reinilde Heyrman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MEDPACE HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2017-08-31 | - |
Career history of Reinilde Heyrman
Former positions of Reinilde Heyrman
| Companies | Position | Start | End |
|---|---|---|---|
| IKARIA, INC. | Corporate Officer/Principal | 2011-12-31 | - |
| BELLEROPHON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2014-01-31 | - |
| Corporate Secretary | 2014-01-31 | - |
Training of Reinilde Heyrman
| University of Antwerp | Doctorate Degree |
Statistics
International
| United States | 4 |
| Belgium | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| MEDPACE HOLDINGS, INC. | Commercial Services |
| Private companies | 1 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
- Stock Market
- Insiders
- Reinilde Heyrman
- Experience
